Ilona Anna Bednarek (Ilona Bednarek)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

International journal of molecular sciences

Biomedicines

Archives of gynecology and obstetrics

Molecular biology reports

Thomas Jefferson University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University Aug 01 1998

United States

postdoctoral research fellow :: Department of Microbiology and Immunology

Allegheny University of the Health Sciences Jul 01 1997 - Jul 31 1998

United States

Research fellow :: Laboratory of NeuroAIDS, Center for NeuroVirology

Publications

Jakub Rech, Dorota Żelaszczyk, Henryk Marona, Agnieszka Gunia-Krzyżak, Paweł Żmudzki, Ilona Anna Bednarek
Hyperthermia Intensifies α-Mangostin and Synthetic Xanthones' Antimalignancy Properties. International journal of molecular sciences 25 (16) (2024)
Magdalena Jurzak, Paweł Ramos, Barbara Pilawa, Ilona Anna Bednarek
Comparative EPR Studies on the Influence of Genistein on Free Radicals in Non-Irradiated and UV-Irradiated MCF7, T47D and MDA-MB-231 Breast Cancer Cells. Biomedicines 12 (3) (2024)
Jakub Rech, Dorota Żelaszczyk, Henryk Marona, Agnieszka Gunia-Krzyżak, Paweł Żmudzki, Ilona Anna Bednarek
Hyperthermia Intensifies α-Mangostin and Synthetic Xanthones' Antimalignancy Properties. International journal of molecular sciences 25 (16) (2024)
Magdalena Jurzak, Paweł Ramos, Barbara Pilawa, Ilona Anna Bednarek
Comparative EPR Studies on the Influence of Genistein on Free Radicals in Non-Irradiated and UV-Irradiated MCF7, T47D and MDA-MB-231 Breast Cancer Cells. Biomedicines 12 (3) (2024)
Aleksandra Zoń, Ilona Anna Bednarek
Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. International journal of molecular sciences 24 (8) (2023)
Aleksandra Zoń, Ilona Anna Bednarek
Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. International journal of molecular sciences 24 (8) (2023)
Aleksandra Zoń, Ilona Anna Bednarek
Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. International journal of molecular sciences 24 (8) (2023)
Aleksandra Zoń, Ilona Anna Bednarek
Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. International journal of molecular sciences 24 (8) (2023)
Paulina Borzdziłowska, Ilona Anna Bednarek
The Effect of α-Mangostin and Cisplatin on Ovarian Cancer Cells and the Microenvironment. Biomedicines 10 (5) (2022)
Paulina Borzdziłowska, Ilona Anna Bednarek
Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts. International journal of molecular sciences 23 (16) (2022)
Jakub Rech, Daniel Sypniewski, Dorota Żelaszczyk, Natalia Szkaradek, Wojciech Rogóż, Anna M Waszkielewicz, Henryk Marona, Ilona Anna Bednarek
Novel Xanthone Derivatives Impair Growth and Invasiveness of Colon Cancer Cells In Vitro. Biomolecules 11 (10) (2021)
Ewa Nowak, Ilona Anna Bednarek
Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis. Cells 10 (12) (2021)
Ewa Nowak, Daniel Sypniewski, Ilona Anna Bednarek
Morin exerts anti-metastatic, anti-proliferative and anti-adhesive effect in ovarian cancer cells: an in vitro studies. Molecular biology reports 47 (3) (2020)
Dominik Bieg, Daniel Sypniewski, Ewa Nowak, Ilona Anna Bednarek
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin. Archives of gynecology and obstetrics 298 (6) (2018)
Dominik Bieg, Daniel Sypniewski, Ewa Nowak, Ilona Anna Bednarek
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin. Archives of gynecology and obstetrics 299 (4) (2018)

Ilona Anna Bednarek.css-eqlu8i{font-size:small;padding-left:4px;} (Ilona Bednarek)

Publication Activity (10 Years)

Top Topics

Top Venues

Ilona Anna Bednarek (Ilona Bednarek)